Your shopping cart is currently empty

12-HETE-d8 is a deuterated form of 12-HETE. As the primary metabolite of arachidonic acid catalyzed by 12-LOX, 12-HETE inhibits apoptosis. It facilitates NF-κB activation and nuclear translocation via the integrin-linked kinase (ILK) pathway. Additionally, 12-HETE exhibits both antithrombotic and prothrombotic effects and serves as a neuromodulator.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | 12-HETE-d8 is a deuterated form of 12-HETE. As the primary metabolite of arachidonic acid catalyzed by 12-LOX, 12-HETE inhibits apoptosis. It facilitates NF-κB activation and nuclear translocation via the integrin-linked kinase (ILK) pathway. Additionally, 12-HETE exhibits both antithrombotic and prothrombotic effects and serves as a neuromodulator. |
| Molecular Weight | 328.52 |
| Formula | C20H32O3 |
| Cas No. | 2525175-25-9 |
| Smiles | C(\C(C/C(=C(\CCCCC)/[2H])/[2H])(O)[2H])(=C/C(=C(\C/C(=C(\CCCC(O)=O)/[2H])/[2H])/[2H])/[2H])/[2H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.